Entries of Zugmaier, Gerhard on the publication server

Gökbuget, Nicola, Zugmaier, Gerhard, Dombret, Hervé, Stein, Anthony, Bonifacio, Massimiliano, Graux, Carlos, Faul, Christoph, Brüggemann, Monika, Taylor, Kate, Mergen, Noemi, Reichle, Albrecht, Horst, Heinz-August, Havelange, Violaine, Topp, Max S. and Bargou, Ralf C. (2020) Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia. Leukemia & Lymphoma 61 (11), pp. 2665-2673. Fulltext not available.

Bargou, Ralf C., Nagorsen, Dirk, Zugmaier, Gerhard, Benjamin, Jonathan E., Haddad, Vincent, Wessels, Hendrik, Stieglmaier, Julia, Havelange, Violaine, Horst, Heinz-August, Brüggemann, Monika, Topp, Max S., Diedrich, Helmut, Faul, Christoph, Graux, Carlos, Reichle, Albrecht, Bonifacio, Massimiliano, Dombret, Hervé and Gökbuget, Nicola (2018) Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood 131 (14), pp. 1522-1531. Fulltext not available.

Zugmaier, Gerhard, Gökbuget, Nicola, Klinger, Matthias, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-A., Marks, Reinhard, Faul, Christoph, Diedrich, Helmut, Reichle, Albrecht, Brüggemann, Monika, Holland, Chris, Schmidt, Margit, Einsele, Hermann, Bargou, Ralf C. and Topp, Max S. (2015) Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment. Blood 126 (24), pp. 2578-2584. Fulltext not available.

Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Klappers, Petra, Stelljes, Matthias, Neumann, Svenja, Viardot, Andreas, Marks, Reinhard, Diedrich, Helmut, Faul, Christoph, Reichle, Albrecht, Horst, Heinz-August, Brüggemann, Monika, Wessiepe, Dorothea, Holland, Chris, Alekar, Shilpa, Mergen, Noemi, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralf C. (2014) Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 32 (36), pp. 4134-4140. Fulltext not available.

Topp, Max, Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz-August, Reichle, Albrecht, Marks, Reinhard, Monika, Brueggemann, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralph (2012) Effect of anti-CD19 BiTE blinatumomab on complete remission rate and overall survival in adult patients with relapsed/refractory B-precursor ALL. Journal of Clinical Oncology 30 (15_sup), p. 6500. Fulltext not available.

Topp, Max S., Goekbuget, Nicola, Zugmaier, Gerhard, Viardot, Andreas, Stelljes, Matthias, Neumann, Svenja, Horst, Heinz A., Reichle, Albrecht, Marks, Reinhard E, Brueggemann, Monika, Ritgen, Matthias, Klappers, Petra, Mergen, Noemi, Goebeler, Marie-Elisabeth, Einsele, Hermann, Hoelzer, Dieter and Bargou, Ralf (2011) Anti-CD19 BiTE Blinatumomab Induces High Complete Remission Rate In Adult Patients with Relapsed B-Precursor ALL: Updated Results of An Ongoing Phase II Trial. Blood 118 (21), p. 252. Fulltext not available.